D‐dimer testing in clinical practice in the era of COVID‐19

D‐dimer is a fragment of crosslinked fibrin resulting from plasmin cleavage of fibrin clots and hence an indirect biomarker of the hemostatic system activation. Early in the coronavirus disease 2019 (COVID‐19) pandemic, several studies described coagulation disorders in affected patients, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Auditeau, Claire, Khider, Lina, Planquette, Benjamin, Sanchez, Olivier, Smadja, David M., Gendron, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133433/
https://www.ncbi.nlm.nih.gov/pubmed/35664536
http://dx.doi.org/10.1002/rth2.12730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133433/
https://www.ncbi.nlm.nih.gov/pubmed/35664536
http://dx.doi.org/10.1002/rth2.12730

Ejemplares similares